V. Favrel

1.2k total citations
22 papers, 492 citations indexed

About

V. Favrel is a scholar working on Surgery, Otorhinolaryngology and Oncology. According to data from OpenAlex, V. Favrel has authored 22 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Otorhinolaryngology and 7 papers in Oncology. Recurrent topics in V. Favrel's work include Head and Neck Cancer Studies (8 papers), Advanced Radiotherapy Techniques (5 papers) and Salivary Gland Tumors Diagnosis and Treatment (5 papers). V. Favrel is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Advanced Radiotherapy Techniques (5 papers) and Salivary Gland Tumors Diagnosis and Treatment (5 papers). V. Favrel collaborates with scholars based in France and United States. V. Favrel's co-authors include O. Chapet, Jean‐Pierre Gérard, P. Romestaing, F. Mornex, P. Pommier, Emmanuel Jouanneau, Sylvie Isaac, Eric Morignat, Gérald Raverot and C. Paulin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

V. Favrel

21 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Favrel France 11 298 201 132 126 101 22 492
B. Dessard-Diana France 8 174 0.6× 95 0.5× 92 0.7× 144 1.1× 17 0.2× 19 297
Shaoqin He China 8 159 0.5× 91 0.5× 133 1.0× 122 1.0× 41 0.4× 11 331
Mikio Ogita Japan 11 159 0.5× 158 0.8× 79 0.6× 165 1.3× 74 0.7× 24 381
Raj Singh United States 11 111 0.4× 266 1.3× 177 1.3× 23 0.2× 71 0.7× 50 485
Jeffrey A. Forquer United States 8 168 0.6× 536 2.7× 101 0.8× 63 0.5× 421 4.2× 14 748
Chad G. Rusthoven United States 11 143 0.5× 161 0.8× 93 0.7× 72 0.6× 34 0.3× 18 355
Anna Santacaterina Italy 11 217 0.7× 148 0.7× 181 1.4× 33 0.3× 68 0.7× 39 443
Pervin Hürmüz Türkiye 12 89 0.3× 239 1.2× 61 0.5× 47 0.4× 89 0.9× 55 381
D.C. Fermont United Kingdom 8 114 0.4× 113 0.6× 112 0.8× 114 0.9× 47 0.5× 10 356
Wilhelmina M.H. Eijkenboom Netherlands 10 512 1.7× 412 2.0× 78 0.6× 95 0.8× 34 0.3× 16 618

Countries citing papers authored by V. Favrel

Since Specialization
Citations

This map shows the geographic impact of V. Favrel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Favrel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Favrel more than expected).

Fields of papers citing papers by V. Favrel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Favrel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Favrel. The network helps show where V. Favrel may publish in the future.

Co-authorship network of co-authors of V. Favrel

This figure shows the co-authorship network connecting the top 25 collaborators of V. Favrel. A scholar is included among the top collaborators of V. Favrel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Favrel. V. Favrel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Favrel, V., et al.. (2019). EP-1815 MCO in VMAT treatment planning for locally advanced head and neck cancer. Radiotherapy and Oncology. 133. S983–S984. 1 indexed citations
3.
Tallet, Agnès, et al.. (2018). Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy. Journal of Applied Clinical Medical Physics. 19(5). 463–472. 31 indexed citations
4.
Marchand, Lucien, et al.. (2015). Dilated Cardiomyopathy Revealing Cushing Disease. Medicine. 94(46). e2011–e2011. 13 indexed citations
5.
Zaouche, S., et al.. (2014). Experience of multidisciplinary team meetings in vestibular schwannoma: a preliminary report. European Archives of Oto-Rhino-Laryngology. 272(11). 3187–3192. 10 indexed citations
6.
Fayette, Jérôme, A. Cosmidis, Sophie Tartas, et al.. (2014). Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck. Drug Design Development and Therapy. 8. 2549–2549. 1 indexed citations
7.
Fayette, Jérôme, Nathalie Bonnin, Céline Ferlay, et al.. (2013). Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab. Anti-Cancer Drugs. 24(6). 623–629. 10 indexed citations
8.
Bari, Berardino De, et al.. (2012). Does weight loss predict accuracy of setup in head and neck cancer patients treated with Intensity-Modulated Radiation Therapy?. La radiologia medica. 117(5). 885–891. 8 indexed citations
9.
Toledano, I., P. Gräff, Pierre Boisselier, et al.. (2012). Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03. Radiotherapy and Oncology. 103(1). 57–62. 102 indexed citations
10.
Jouanneau, Emmanuel, Anne Wierinckx, François Ducray, et al.. (2011). New targeted therapies in pituitary carcinoma resistant to temozolomide. Pituitary. 15(1). 37–43. 76 indexed citations
11.
Guittard, Laure, Anne-Laure Charlois, Laurent Letrilliart, et al.. (2007). Shared medical information: Expectations of breast cancer patients. Gynecologic Oncology. 107(3). 474–481. 4 indexed citations
12.
Chapet, O., Jean‐Pierre Gérard, F. Mornex, et al.. (2006). Prognostic factors of squamous cell carcinoma of the anal margin treated by radiotherapy: the Lyon experience. International Journal of Colorectal Disease. 22(2). 191–199. 18 indexed citations
13.
Chapet, O., P. Romestaing, F. Mornex, et al.. (2005). Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?. International Journal of Radiation Oncology*Biology*Physics. 61(5). 1371–1377. 40 indexed citations
14.
Scodan, Romuald Le, P. Pommier, X. Montbarbon, et al.. (2005). Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: Results in 44 patients. International Journal of Radiation Oncology*Biology*Physics. 63(2). 441–448. 11 indexed citations
15.
Baron, Marie, et al.. (2004). A “One-day survey”: As a reliable estimation of the potential recruitment for proton- and carbon- ion therapy in France. Radiotherapy and Oncology. 73. S15–S17. 19 indexed citations
16.
Gérard, Jean‐Pierre, O. Chapet, Eric Morignat, et al.. (2001). Management of inguinal lymph node metastases in patients with carcinoma of the anal canal. Cancer. 92(1). 77–84. 114 indexed citations
17.
Favrel, V., et al.. (2001). Processus de production en radiothérapie externe et recherche d’inducteurs de coûts dans deux services hospitaliers. Cancer/Radiothérapie. 5(1). 23–34. 2 indexed citations
18.
Gérard, Jean‐Pierre, et al.. (2000). [Local excision and adjuvant radiotherapy for rectal adenocarcinoma T1-2 N0].. PubMed. 24(4). 430–5. 11 indexed citations
19.
Clippe, Sébastien, Francisco Gómez Gómez, P. Pommier, et al.. (2000). 29 Role of 192 IR interstitial brachytherapy in the treatment of tumors of Glosso-Epiglottic fold with functional supraglottic laryngectomy. Radiotherapy and Oncology. 55. 22–22. 1 indexed citations
20.
Prades, J.-M., V. Favrel, N. Barbet, et al.. (1997). IORT for Locally Advanced Oropharyngeal Carcinomas with Major Extension to the Base of the Tongue: 5-Year Results of a Prospective Study. Frontiers of radiation therapy and oncology. 31. 117–121. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Dessard-Diana Breakdown of academic impact, for papers by Shaoqin He Breakdown of academic impact, for papers by Mikio Ogita Breakdown of academic impact, for papers by Raj Singh Breakdown of academic impact, for papers by Jeffrey A. Forquer Breakdown of academic impact, for papers by Chad G. Rusthoven Breakdown of academic impact, for papers by Anna Santacaterina Breakdown of academic impact, for papers by Pervin Hürmüz Breakdown of academic impact, for papers by D.C. Fermont Breakdown of academic impact, for papers by Wilhelmina M.H. Eijkenboom
Rankless by CCL
2026